BRIEF-Merck Expects 2026 Sales $65.5 Billion-$67.0 Billion vs IBES Estimate $67.60 BillionFeb 3 (Reuters) - Merck & Co Inc MRK.N:
MERCK OUTLOOK 2026 ADJUSTED EPS $5.00 - $5.15 VERSUS IBES ESTIMATE $5.36
MERCK Q4 ADJUSTED EPS $2.04 VERSUS IBES ESTIMATE $2.01
MERCK OUTLOOK 2026 SALES $65.5 BILLION- $67.0 BILLION VERSUS IBES ESTIMATE $67.60 BILLION
MERCK: 2026 OUTLOOK REFLECTS ONE-TIME CHARGE OF ABOUT $3.65 PER SHARE FOR ACQUISITION OF CIDARA
MERCK Q4 WORLDWIDE SALES $16.40 BILLION VERSUS IBES ESTIMATE $16.19 BILLION
MERCK Q4 WORLDWIDE KEYTRUDA SALES $8.37 BILLION
Further company coverage: MRK.N
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments